Matches in Nanopublications for { ?s ?p "[Transthyretin familial amyloid polyneuropathies (TTR-FAPs) are autosomal dominant neuropathies of fatal outcome within 10 years after inaugural symptoms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 3 of
3
with 100 items per page.
- NP625081.RAD4RV58YxvBoRGFQntpW0IdaHPYdH18P8ubObEXkVL9M130_assertion description "[Transthyretin familial amyloid polyneuropathies (TTR-FAPs) are autosomal dominant neuropathies of fatal outcome within 10 years after inaugural symptoms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP625081.RAD4RV58YxvBoRGFQntpW0IdaHPYdH18P8ubObEXkVL9M130_provenance.
- NP761870.RAbtJgKQfv4iP8hPpnkPZ0HTygNzfpYP1E-1FAeFwdorQ130_assertion description "[Transthyretin familial amyloid polyneuropathies (TTR-FAPs) are autosomal dominant neuropathies of fatal outcome within 10 years after inaugural symptoms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP761870.RAbtJgKQfv4iP8hPpnkPZ0HTygNzfpYP1E-1FAeFwdorQ130_provenance.
- assertion description "[Transthyretin familial amyloid polyneuropathies (TTR-FAPs) are autosomal dominant neuropathies of fatal outcome within 10 years after inaugural symptoms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.